Clearly, gene amplification rate might also be relevant when investigating the role of Myc, but there is already sufficient data showing a clear correlation between increased amplification of Myc and a poor outcome in various malignancies including SCLC [44–46]. The gene discussed is MYC; the disease is small cell lung carcinoma.